
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
PROTEINA has developed a first-in-class protein-protein interaction (PPI) analysis platform using proprietary single-molecule co-immunoprecipitation technology. Our platform enables quantitative PPI measurements at the single-molecule level, delivering analyses with unparalleled accuracy and speed. PROTEINA has accumulated extensive know-how in developing assays measuring targeted PPIs as well as the analytic capability to model the efficacy of a drug based on its PPI metrics. Our mission is to revolutionize protein analysis; developing effective, new approaches to diagnosing diseases and discovering new drug candidates using our novel technology. For more information regarding PROTEINA, please visit us at www.proteina.co.kr
Protein science,cancer research,biotechnology,biotechnology laboratory,single-molecule co-immunoprecipitation technology,proteomics,protein-protein interactions,ppi,ai drug discovery,and affinity maturation
Proteina operates in the Biotechnology research industry.
Proteina's revenue is 11m - 100m
Proteina has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.